• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

携带 rpoB Ser531Leu(临床分离株中最常见的利福平耐药突变)的菌株中代偿进化的遗传特征。

Genetic characterization of compensatory evolution in strains carrying rpoB Ser531Leu, the rifampicin resistance mutation most frequently found in clinical isolates.

机构信息

Department of Medical Biochemistry and Microbiology, Box 582 Biomedical Center, Uppsala University, Uppsala, Sweden.

出版信息

J Antimicrob Chemother. 2013 Nov;68(11):2493-7. doi: 10.1093/jac/dkt224. Epub 2013 Jun 11.

DOI:10.1093/jac/dkt224
PMID:23759506
Abstract

OBJECTIVES

The evolution of rifampicin resistance in Mycobacterium tuberculosis is a major threat to effective tuberculosis therapy. Much is known about the initial emergence of rifampicin resistance, but the further evolution of these resistant strains has only lately been subject to investigation. Although resistance can be caused by many different mutations in rpoB, among clinical M. tuberculosis isolates the mutation rpoB S531L is overwhelmingly the most frequently found. Clinical isolates with rpoB S531L frequently carry additional mutations in genes for RNA polymerase subunits, and it has been speculated that these are fitness-compensatory mutations, ameliorating the fitness cost of the primary resistance mutation. We tested this hypothesis using Salmonella as a model organism.

METHODS

We created the rpoB S531L mutation in Salmonella and then evolved independent lineages with selection for mutants with increased relative fitness. Relative fitness associated with putative compensatory mutations was measured after genetic reconstruction in isogenic strains.

RESULTS

Compensatory mutations were identified in genes coding for different subunits of RNA polymerase: rpoA, rpoB and rpoC. Genetic reconstructions demonstrated that each of these secondary mutations reduced the fitness cost of the rpoB S531L resistance mutation.

CONCLUSIONS

The compensatory mutations identified in Salmonella cluster in similar locations to the additional mutations found in M. tuberculosis isolates. These new data strongly support the idea that many of the previously identified rpoA, rpoB and rpoC mutations in rifampicin-resistant M. tuberculosis (rpoB S531L) are indeed fitness-compensatory mutations.

摘要

目的

结核分枝杆菌利福平耐药性的进化是有效治疗结核病的主要威胁。人们对利福平耐药性的最初出现有了很多了解,但这些耐药菌株的进一步进化最近才受到关注。虽然 rpoB 中的许多不同突变都可能导致耐药性,但在临床结核分枝杆菌分离株中,rpoB S531L 突变是最常见的。具有 rpoB S531L 突变的临床分离株经常携带 RNA 聚合酶亚基基因的其他突变,人们推测这些是适应性补偿突变,可以减轻主要耐药突变的适应性代价。我们使用沙门氏菌作为模型生物来验证这一假说。

方法

我们在沙门氏菌中创建了 rpoB S531L 突变,然后通过选择具有更高相对适应性的突变体来进化独立的谱系。在同基因菌株中进行遗传重建后,测量与假定补偿突变相关的相对适应性。

结果

鉴定出与 RNA 聚合酶不同亚基编码的补偿突变:rpoA、rpoB 和 rpoC。遗传重建表明,这些二次突变中的每一个都降低了 rpoB S531L 耐药突变的适应性代价。

结论

在沙门氏菌中鉴定出的补偿突变与在结核分枝杆菌分离株中发现的额外突变聚集在相似的位置。这些新数据有力地支持了这样一种观点,即以前在耐利福平的结核分枝杆菌(rpoB S531L)中鉴定出的许多 rpoA、rpoB 和 rpoC 突变确实是适应性补偿突变。

相似文献

1
Genetic characterization of compensatory evolution in strains carrying rpoB Ser531Leu, the rifampicin resistance mutation most frequently found in clinical isolates.携带 rpoB Ser531Leu(临床分离株中最常见的利福平耐药突变)的菌株中代偿进化的遗传特征。
J Antimicrob Chemother. 2013 Nov;68(11):2493-7. doi: 10.1093/jac/dkt224. Epub 2013 Jun 11.
2
Fitness-compensatory mutations in rifampicin-resistant RNA polymerase.利福平耐药 RNA 聚合酶中的适应性补偿突变。
Mol Microbiol. 2012 Jul;85(1):142-51. doi: 10.1111/j.1365-2958.2012.08099.x. Epub 2012 May 31.
3
Comprehensive phenotypic characterization of rifampicin resistance mutations in Salmonella provides insight into the evolution of resistance in Mycobacterium tuberculosis.对沙门氏菌利福平耐药突变进行全面表型特征分析,深入了解结核分枝杆菌耐药性的进化。
J Antimicrob Chemother. 2015 Mar;70(3):680-5. doi: 10.1093/jac/dku434. Epub 2014 Oct 31.
4
Compensatory effects of mutations outside the rifampicin resistance-determining region.突变在利福平耐药决定区之外的补偿作用。
Emerg Microbes Infect. 2021 Dec;10(1):743-752. doi: 10.1080/22221751.2021.1908096.
5
Putative compensatory mutations in the rpoC gene of rifampin-resistant Mycobacterium tuberculosis are associated with ongoing transmission.利福平耐药结核分枝杆菌 rpoC 基因的假定补偿突变与持续传播有关。
Antimicrob Agents Chemother. 2013 Feb;57(2):827-32. doi: 10.1128/AAC.01541-12. Epub 2012 Dec 3.
6
Determination of potentially novel compensatory mutations in rpoc associated with rifampin resistance and rpob mutations in Clinical isolates from peru.鉴定秘鲁临床分离株中与利福平耐药相关的 rpoc 潜在新型补偿突变和 rpob 突变。
Int J Mycobacteriol. 2020 Apr-Jun;9(2):121-137. doi: 10.4103/ijmy.ijmy_27_20.
7
Evidence for the critical role of a secondary site rpoB mutation in the compensatory evolution and successful transmission of an MDR tuberculosis outbreak strain.继发位点rpoB突变在耐多药结核暴发菌株的代偿进化和成功传播中的关键作用的证据。
J Antimicrob Chemother. 2016 Feb;71(2):324-32. doi: 10.1093/jac/dkv345. Epub 2015 Nov 3.
8
Correlation of mutations detected by INNO-LiPA with levels of rifampicin resistance in Mycobacterium tuberculosis.INNO-LiPA检测到的突变与结核分枝杆菌中利福平耐药水平的相关性。
Indian J Med Res. 2004 Aug;120(2):100-5.
9
Rapid detection of mutations in rpoB gene of rifampicin resistant Mycobacterium tuberculosis strains by line probe assay.采用线性探针分析法快速检测耐利福平结核分枝杆菌菌株rpoB基因的突变
Indian J Med Res. 2003 Feb;117:76-80.
10
Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates.耐利福平临床结核分枝杆菌分离株中I簇区域内外rpoB基因突变的频率。
J Clin Microbiol. 2001 Jan;39(1):107-10. doi: 10.1128/JCM.39.1.107-110.2001.

引用本文的文献

1
Multidrug-resistant tuberculosis clusters and transmission in Taiwan: a population-based cohort study.台湾地区耐多药结核病聚集性病例及传播情况:一项基于人群的队列研究
Front Microbiol. 2024 Sep 18;15:1439532. doi: 10.3389/fmicb.2024.1439532. eCollection 2024.
2
Genetic diversity, evolution and drug resistance of lineage 2.2型谱系的遗传多样性、进化及耐药性
Front Microbiol. 2024 May 17;15:1384791. doi: 10.3389/fmicb.2024.1384791. eCollection 2024.
3
Novel automated AIMLAM for diagnosis of .新型自动化 AIMLAM 用于. 的诊断。
Future Microbiol. 2024 Jun 12;19(9):783-793. doi: 10.2217/fmb-2024-0025. Epub 2024 Apr 9.
4
Compensatory evolution in NusG improves fitness of drug-resistant M. tuberculosis.NusG 的补偿进化提高了耐多药结核分枝杆菌的适应性。
Nature. 2024 Apr;628(8006):186-194. doi: 10.1038/s41586-024-07206-5. Epub 2024 Mar 20.
5
Phenotypic and Genotypic Drug Resistance of Strains Isolated from HIV-Infected Patients from a Third-Level Public Hospital in Mexico.从墨西哥一家三级公立医院的艾滋病毒感染患者中分离出的菌株的表型和基因型耐药性
Pathogens. 2024 Jan 23;13(2):98. doi: 10.3390/pathogens13020098.
6
Repurposing Azoles to Resolve Serotogenic Toxicity Associated with Linezolid to Combat Multidrug-Resistant Tuberculosis.重新利用唑类药物来解决与利奈唑胺相关的5-羟色胺生成毒性,以对抗耐多药结核病。
ACS Med Chem Lett. 2023 Nov 1;14(12):1754-1759. doi: 10.1021/acsmedchemlett.3c00406. eCollection 2023 Dec 14.
7
Genomic Characterization of Drug-Resistant L2/Beijing Isolates from Astana, Kazakhstan.来自哈萨克斯坦阿斯塔纳的耐多药L2/北京基因型菌株的基因组特征分析
Antibiotics (Basel). 2023 Oct 10;12(10):1523. doi: 10.3390/antibiotics12101523.
8
Chance Favors the Prepared Genomes: Horizontal Transfer Shapes the Emergence of Antibiotic Resistance Mutations in Core Genes.机遇偏爱有准备的基因组:水平转移塑造核心基因中抗生素耐药性突变的出现。
Mol Biol Evol. 2023 Oct 4;40(10). doi: 10.1093/molbev/msad217.
9
Borderline mutations transmit at the same rate as common mutations in a tuberculosis cohort in Bangladesh.孟加拉国结核队列中,交界突变的传播率与常见突变相同。
Microb Genom. 2023 Sep;9(9). doi: 10.1099/mgen.0.001109.
10
The evolving biology of drug resistance.耐药性的不断演变的生物学。
Front Cell Infect Microbiol. 2022 Oct 5;12:1027394. doi: 10.3389/fcimb.2022.1027394. eCollection 2022.